share_log

Piper Sandler Maintains Neutral on Enfusion, Raises Price Target to $11.5

Benzinga ·  Dec 23 20:28  · Ratings

Piper Sandler analyst Sumeet Mody maintains Enfusion (NYSE:ENFN) with a Neutral and raises the price target from $10 to $11.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment